Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
BENSALEM, Pa., June 22, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded
ATTENTION ADMA INVESTORS: Contact Berger Montague About an ADMA Biologics, Inc. Class Action Lawsuit
12:21pm, Monday, 22'nd Jun 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - June 22, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Monday, 22'nd Jun 2026
New York, New York--(Newsfile Corp. - June 22, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed agains
ADMA Biologics allegedly used channel stuffing to inflate ASCENIV revenues by millions, turning reported 20% growth into an estimated 3% decline, according to a new securities class action ADMA Biolog
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel st
ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
05:00am, Monday, 22'nd Jun 2026
ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA PR Newswire
ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
04:29am, Monday, 22'nd Jun 2026
LOS ANGELES, June 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of §§10(
The law firm of [url="]Robbins Geller Rudman and Dowd LLP[/url] announces that purchasers or acquirers of ADMA Biologics, Inc. (NASDAQ: ADMA) publicly traded secu
SAN DIEGO--(BUSINESS WIRE)---- $ADMA #ADMA--The case alleges ADMA Biologics and certain of its executives made false and/or misleading statements to investors.
3 Biotech Firms With Major Potential Catalysts in the Coming Months
10:31am, Sunday, 21'st Jun 2026
As Big Pharma braces for a looming patent cliff that threatens billions in revenue, a different group of companies is chasing the opposite story: a single breakthrough that could define their future.
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
08:00am, Sunday, 21'st Jun 2026
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm PR Newswire
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
07:58am, Sunday, 21'st Jun 2026
NEW YORK, June 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and Marc
New York, New York--(Newsfile Corp. - June 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick and Foti, L
/PRNewswire/ -- Kahn Swick and Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ADMA
